Pulmonary and cerebral irradiation for hyperleukocytosis in acute myelomonocytic leukemia

A dynamic anthropomorphic phantom for end-to-end testing in image- and surface-guided adaptive radiotherapy.

Medical physics·2025

30 years of ocular proton therapy, the Nice view.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2022

Ocular proton therapy, pencil beam scanning high energy proton therapy or stereotactic radiotherapy for uveal melanoma; an in silico study.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2022

[Results of surgical and radiotherapeutic treatment of adenoid cystic carcinoma of the salivary glands].

HNO·2020

Secondary malignancies in chronic myeloid leukemia patients after imatinib-based treatment: long-term observation in CML Study IV.

Leukemia·2016

[Malignant tumours of the eye: Epidemiology, diagnostic methods and radiotherapy].

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2015

Mitochondria transfer via tunneling nanotubes drives macrophage immunosuppression and metabolic reprogramming in pediatric AML.

Leukemia·2026

Bone health in myelodysplastic neoplasms: results from the prospective longitudinal BoHemE study.

Leukemia·2026

RUNX1 aberrations in blast-phase chronic myeloid leukaemia induce the RNA-binding protein SPATS2L, which promotes growth, survival and stress granule assembly.

Leukemia·2026

Predicting the clinical course of advanced systemic mastocytosis on treatment with avapritinib or midostaurin.

Leukemia·2026

Novel RNA polymerase I and cyclin-dependent kinase combination therapy for the treatment of aggressive acute myeloid leukemia.

Leukemia·2026

Measurable residual disease assessment as an early end point of treatment efficacy in acute myeloid leukemia: a multinational PETHEMA study of 2623 patients treated with intensive therapy.

Leukemia·2026

Exosomes From Toll-Like Receptor 4-Stimulated Lung Cancer Cells Modulate Macrophage Polarization.

Scandinavian journal of immunology·2026

Inhibition of CCN2/CTGF prevents heterotopic ossification in Fibrodysplasia Ossificans Progressiva.

Molecular therapy : the journal of the American Society of Gene Therapy·2026

First-in-human phase Ia study of the covalent TEAD palmitoylation inhibitor BPI-460372 in patients with advanced solid tumors: pharmacokinetics, exposure-limited dosing, and early antitumor activity.

Biomarker research·2026

RNA N4-acetylcytidine modification in health and cancer: molecular mechanisms, cellular plasticity, and therapeutic opportunities.

Biomarker research·2026

Solitary laryngeal plasmacytoma treated by TOMES: Case report and review of the literature.

European annals of otorhinolaryngology, head and neck diseases·2026

Related Experiment Videos

Pulmonary and cerebral irradiation for hyperleukocytosis in acute myelomonocytic leukemia

Related Concept Videos

A dynamic anthropomorphic phantom for end-to-end testing in image- and surface-guided adaptive radiotherapy.

30 years of ocular proton therapy, the Nice view.

Ocular proton therapy, pencil beam scanning high energy proton therapy or stereotactic radiotherapy for uveal melanoma; an in silico study.

[Results of surgical and radiotherapeutic treatment of adenoid cystic carcinoma of the salivary glands].

Secondary malignancies in chronic myeloid leukemia patients after imatinib-based treatment: long-term observation in CML Study IV.

[Malignant tumours of the eye: Epidemiology, diagnostic methods and radiotherapy].

Mitochondria transfer via tunneling nanotubes drives macrophage immunosuppression and metabolic reprogramming in pediatric AML.

Bone health in myelodysplastic neoplasms: results from the prospective longitudinal BoHemE study.

RUNX1 aberrations in blast-phase chronic myeloid leukaemia induce the RNA-binding protein SPATS2L, which promotes growth, survival and stress granule assembly.

Predicting the clinical course of advanced systemic mastocytosis on treatment with avapritinib or midostaurin.

Novel RNA polymerase I and cyclin-dependent kinase combination therapy for the treatment of aggressive acute myeloid leukemia.

Measurable residual disease assessment as an early end point of treatment efficacy in acute myeloid leukemia: a multinational PETHEMA study of 2623 patients treated with intensive therapy.

Exosomes From Toll-Like Receptor 4-Stimulated Lung Cancer Cells Modulate Macrophage Polarization.

Inhibition of CCN2/CTGF prevents heterotopic ossification in Fibrodysplasia Ossificans Progressiva.

First-in-human phase Ia study of the covalent TEAD palmitoylation inhibitor BPI-460372 in patients with advanced solid tumors: pharmacokinetics, exposure-limited dosing, and early antitumor activity.

RNA N4-acetylcytidine modification in health and cancer: molecular mechanisms, cellular plasticity, and therapeutic opportunities.

Solitary laryngeal plasmacytoma treated by TOMES: Case report and review of the literature.

Related Experiment Videos

Pulmonary and cerebral irradiation for hyperleukocytosis in acute myelomonocytic leukemia

Related Concept Videos

Related Articles